Simposi
Type 2 Diabetes: Glycemic Control And Innovation Therapy
26 ottobre 2017 / 12.30-13.00
| 178 |
Glycemic control in type 2 Diabetes: clinical benefit and barriers to insulin intensification Giorgio Sesti (Catanzaro) |
| 179 |
A new combination therapy for type 2 Diabetes: Basal insulin plus GLP- 1 receptor agonists,from phisiophatology to sinergy of actions Giovambattista De Sarro (Catanzaro) |